• ABOUT US

    • Company Overview
    • Mission
    • History
    • Network
  • Vaccine KHUB

    • KHUB Consortium
    • Immunocyte Profiling
    • Process Development
    • Global Partner
  • TECHNOLOGY

    • NGS
    • Microarray
    • Single cell WGA
    • Liquid Biopsy
    • AI Algorithm
    • Microbiome
    • Vaccine Platform Technologies
    • PCR
  • OUR SERVICE

    • GenomeCheck
    • COVID-19
    • PCR Kit/Reagent
  • IR

    • Notice
    • Patents
    • Papers
    • Certificate
    • IR
    • Media
  • NEWSROOM

    • Market News
    • Company News
MARKET NEWS COMPANY NEWS
  • Bio Vaccine

    식약처, 코로나 부스터샷•다가 백신 개발 방향 안내

    2022-06-30
    Learn more
  • Bio Vaccine

    식약처 "바이오의약품 표준화 분야 국제협력 선도"

    2022-06-23
    Learn more
  • Gene Analysis

    생명공학의 열쇠 RNA

    2022-06-19
    Learn more
  • Diagnostics

    정확한 비소세포폐암 유전자 변이 진단…치료 성과 보인다

    2022-06-07
    Learn more
  • mRNA

    "mRNA백신 다음 과제는 독감 콤보"…신발끈 묶는 국내 기업들

    2022-05-31
    Learn more
  • Bio Vaccine

    "코로나19 백신, 후유증 예방 효과 예상보다 적다"

    2022-05-26
    Learn more
  • Gene Analysis

    대부분의 유전병은 다수의 '흔한 변이' 조합으로 생긴다

    2022-05-19
    Learn more
  • Bio Vaccine

    New vaccine to treat cancer is now being trialled in Britons with prostate, lung and ovarian tumours

    2022-05-10
    Learn more
  • Diagnostics

    Molecular Profiling Advances Diagnosis, Treatment of Skin Diseases

    2022-04-15
    Learn more
  • Gene Analysis

    내 유전자만 고려한 ‘맞춤약’ 시대 열릴까

    2022-04-11
    Learn more
  • Diagnostics

    코로나19 변이 감염도 현장에서 빠르게 진단한다

    2022-04-04
    Learn more
  • Bio Vaccine

    복지부, 국제백신연구소, 백신 개발 · 바이오인력양성 등 협력

    2022-04-01
    Learn more
  • Gene Analysis

    악성 뇌종양 ‘교모세포종’ 원인 면역유전자 확인

    2022-03-24
    Learn more
  • Gene Analysis

    마이크로바이옴'으로 당뇨병 예측 시대 열릴까

    2022-03-18
    Learn more
  • Gene Analysis

    NGS 데이터 업무 부담…자동화 솔루션 해법

    2022-03-11
    Learn more
  • Bio Vaccine

    올해 바이오헬스 예산 1조8800억…전년比 7% 상승

    2022-03-07
    Learn more
  • Gene Analysis

    초고속 제조 '디지털 백신' 도래… 항원 자체 코딩 유전 정보만 필요

    2022-02-28
    Learn more
  • mRNA

    RNA치료제 시장 성장세 ...코로나19 이후 임상 활발

    2022-02-21
    Learn more
  • mRNA

    美CDC "임신 중 코로나 백신접종, 신생아 보호 효과 있다"

    2022-02-16
    Learn more
  • mRNA

    코로나 백신 기술, 간암 치료에 이용(연구)

    2022-02-10
    Learn more
  • Gene Analysis

    Genetic scissors' can give rise to unforeseen heritable mutations

    2022-02-02
    Learn more
  • Gene Analysis

    “유전체 DB 분석으로 바이러스 10만 개 새로 발견”

    2022-01-27
    Learn more
  • Bio Vaccine

    다가오는 '바이오' 패권시대…생명과학 육성에 미래 달렸다

    2022-01-20
    Learn more
  • Bio Vaccine

    Cancer vaccine breakthrough: Trial for terminally ill patients 'could change landscape'

    2022-01-17
    Learn more
  • Gene Analysis

    우연히 발견한 유전자 변이, 알려야 할까?

    2022-01-11
    Learn more
  • mRNA

    코로나 백신 mRNA 기술로 '심장 섬유증' T세포 치료법 개발

    2022-01-07
    Learn more
  • Bio Vaccine

    Which Antibodies Can Neutralize Omicron?

    2022-01-04
    Learn more
  • mRNA

    "역량 총동원"…政 '글로벌 백신 허브’ 천명

    2021-12-31
    Learn more
  • mRNA

    Scientists Taking Lessons From mRNA Technology Used For COVID Vaccines

    2021-12-27
    Learn more
  • mRNA

    mRNA Will Do More than Conquer COVID

    2021-12-24
    Learn more
  • mRNA

    차세대 혁신 신약 개발, mRNA 이어 마이크로 RNA 뜬다

    2021-12-21
    Learn more
  • Gene Analysis

    “폐암 NGS 패널 검사, 기적을 만드는 도구입니다

    2021-12-15
    Learn more
  • Gene Analysis

    Bringing NGS-Based Testing Closer to Home: The Need for Wider Access

    2021-12-10
    Learn more
  • Bio Vaccine

    The Omicron Variant Highlights the Need for Smarter, Future-Proof Vaccine Design

    2021-12-07
    Learn more
  • Digital Therapeutics

    Study analyzes the contribution of AI to cancer patient care and vaccine design

    2021-12-07
    Learn more
  • Gene Analysis

    New Study Shows How Ancestry Shapes Our Immune Response

    2021-11-25
    Learn more
  • mRNA

    코리컴퍼니, 美 인피니플루딕스와 mRNA 백신 신제조 공법 전략적 파트너십 계약

    2021-11-18
    Learn more
  • Gene Analysis

    바이러스 정복하는 유전자 가위 기술

    2021-11-08
    Learn more
  • Bio Vaccine

    First patient treated with novel Cancer Vaccine

    2021-11-04
    Learn more
  • mRNA

    Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?

    2021-11-01
    Learn more
  • K-HUB

    한미사이언스-英 옥스퍼드대, 팬데믹 사이언스 동맹 협약 체결

    2021-10-28
    Learn more
  • Bio Vaccine

    Immune response to mRNA COVID vaccines delayed in pregnant women

    2021-10-25
    Learn more
  • Investment

    Mr Chong-Yoon Lim of Hanmi Science appointed as a Director

    2021-10-25
    Learn more
  • Bio Vaccine

    An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

    2021-10-20
    Learn more
  • Bio Vaccine

    Is mRNA the Future of Drug Development?

    2021-10-19
    Learn more
  • Bio Vaccine

    Should you mix and match COVID-19 vaccines? Experts weigh in.

    2021-10-18
    Learn more
  • Bio Vaccine

    기술 확보 나선 mRNA…원부자재 국산화 숙제

    2021-10-17
    Learn more
  • Digital Therapeutics

    ‘디지털 치료제’ 새 패러다임 될까?

    2021-10-08
    Learn more
  • Bio Vaccine

    테라젠바이오•엔에이백신연구소, 항암백신 개발 협력

    2021-09-28
    Learn more
  • Digital Therapeutics

    "게임ㆍ앱으로 조현병, 고혈압 치료"…‘디지털 치료제’ 상용화 속도

    2021-09-23
    Learn more
  • Investment

    Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix

    2021-08-31
    Learn more
  • Investment

    인천경제청 바이오헬스 비즈니스 생태계 조성 총력

    2021-08-31
    Learn more
  • Digital Therapeutics

    FDA, 뇌졸증 회복 돕는 '디지털 치료제' 승인

    2021-08-30
    Learn more
  • Digital Therapeutics

    코로나19로 디지털치료제 수요 ↑…美 FDA, 올해만 6개 허가

    2021-08-26
    Learn more
  • K-HUB

    Hanmi Science consortium aims to be Asia-Pacific region’s vaccine hub

    2021-08-25
    Learn more
  • Bio Vaccine

    에스티팜, 테라젠바이오와 ‘mRNA 항암백신’ 연구개발 나선다

    2021-08-18
    Learn more
  • Bio Vaccine

    Hanmi Science has completed the development of six types of raw materials for mRNA vaccines

    2021-08-17
    Learn more
  • K-HUB

    한미약품, mRNA 코로나 백신 개발에 나서… “개발되면 모더나보다 경쟁력 있어”

    2021-08-10
    Learn more
  • Bio Vaccine

    MHRA approval for Phase 1 trial of lead cancer vaccine OVM-200

    2021-08-10
    Learn more
  • Bio Vaccine

    테라젠바이오, '시그니처 유전자' 활용 맞춤형 항암제 선별 기술 특허

    2021-08-09
    Learn more
  • Bio Vaccine

    S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer

    2021-08-05
    Learn more
  • Digital Therapeutics

    진단•의료기기 분야 3354억 유입…디지털 치료제 '주목'

    2021-08-05
    Learn more
  • Digital Therapeutics

    디지털헬스산업, 코로나19로 급부상…규제개선 필수'

    2021-08-02
    Learn more
  • Digital Therapeutics

    디지털치료제, 비만•당뇨로 범위 확장…

    2021-07-28
    Learn more
  • Bio Vaccine

    한미약품그룹-레고켐바이오, 이중항체 ADC 항암신약 공동개발

    2021-07-23
    Learn more
  • Digital Therapeutics

    ‘디지털 치료제’ 시장 급성장 전망...펀드 시장도 움직인다

    2021-07-14
    Learn more
  • Bio Vaccine

    Hanmi Science Aims to Grow into Global Vaccine Hub Company

    2021-07-06
    Learn more
  • K-HUB

    mRNA 준비된 한미약품, WHO '백신허브' 선정 노린다

    2021-07-06
    Learn more
  • Bio Vaccine

    NIH visits Hanmi Fine Chemical to verify mRNA technology

    2021-07-01
    Learn more
  • Bio Vaccine

    한미정밀화학 "국립보건연구원이 방문해 mRNA원료기술 현장검증"

    2021-07-01
    Learn more
  • K-HUB

    Team Korea formed to develop mRNA vaccine for complete self-sufficiency by next yr

    2021-06-30
    Learn more
  • Digital Therapeutics

    떠오르는 디지털 치료제, '대형 제약사' 관심도 증가

    2021-06-18
    Learn more
  • K-HUB

    What policy does Korea need to achieve vaccine hub ambition?

    2021-06-17
    Learn more
  • Bio Vaccine

    임종윤 한미사이언스 대표 “mRNA 백신 원액 단기간 내 공급 가능하다”

    2021-06-16
    Learn more
  • Bio Vaccine

    "백신 개발은 방위산업…컨소시엄 구축하고 대규모 투자로 자체 mRNA 개발해야"

    2021-06-15
    Learn more
  • Bio Vaccine

    G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021

    2021-06-13
    Learn more
  • Bio Vaccine

    한미사이언스-진원생명과학, mRNA 백신 생산기술 공동연구 추진

    2021-05-31
    Learn more
  • Investment

    "6년간 1조 투자"…바이오 빅데이터 뜬다

    2021-05-28
    Learn more
  • Digital Therapeutics

    신약개발에 AI•빅데이터 장착…속도•성공률 높인다

    2021-05-27
    Learn more
  • Digital Therapeutics

    의료 IT 이끄는 대학병원…'디지털 치료제' 개발도 본격화

    2021-05-24
    Learn more
  • K-HUB

    Korea to become global vaccine hub in partnership with US

    2021-05-23
    Learn more
  • Digital Therapeutics

    DTC로 더욱 간편해지는 유전자 검사, 그 가능성은?

    2021-05-22
    Learn more
  • K-HUB

    South Korean firms to forge vaccine alliance in anticipation of patent waiver

    2021-05-18
    Learn more
  • Digital Therapeutics

    바이오코리아2021, 4차 산업혁명시대 데이터융합 혁신기술 조망

    2021-05-12
    Learn more
  • Digital Therapeutics

    '국내서도 ‘꿈틀’…藥 패러다임 바꾸는 전자약

    2021-04-21
    Learn more
  • Digital Therapeutics

    게임과 가상현실로 병을 치료한다고? 성큼 다가온 디지털치료제 시대

    2021-04-21
    Learn more
  • Digital Therapeutics

    '포스트 코로나' 유망분야로 디지털치료제, 헬스케어 뜬다

    2021-04-20
    Learn more
  • Digital Therapeutics

    한발짝 더 다가온 미래藥...전자약•디지털치료제

    2021-04-19
    Learn more
  • Digital Therapeutics

    정밀의료 기업들, 국내 DTC 시장 저변 넓히나

    2021-04-06
    Learn more
  • Bio Vaccine

    Hanmi goes beyond pharmaceuticals

    2020-01-01
    Learn more

(08510) 서울시 금천구 디지털로 173, 10 층 (가산동, 엘리시아)

지놈체크문의 : 02-890-8709

주식 업무 : 02-6964-8770

Fax : 02-890-8702

대표번호 : 02-890-8700

검사결과 조회 바로가기

개인정보처리방침

copyright©2021 Dx&Vx. All rights reserved.

  • ABOUT US

    • Company Overview
    • Mission
    • History
    • Network
  • Vaccine KHUB

    • KHUB Consortium
    • Immunocyte Profiling
    • Process Development
    • Global Partner
  • TECHNOLOGY

    • NGS
    • Microarray
    • Single cell WGA
    • Liquid Biopsy
    • AI Algorithm
    • Microbiome
    • Vaccine Platform Technologies
    • PCR
  • OUR SERVICE

    • GenomeCheck
    • COVID-19
    • PCR Kit/Reagent
  • IR

    • Notice
    • Patents
    • Papers
    • Certificate
    • IR
    • Media
  • NEWSROOM

    • Market News
    • Company News